{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:58:39Z","timestamp":1790510319533,"version":"4.1.0"},"reference-count":16,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals Incubating Program","doi-asserted-by":"publisher","award":["PX2018009"],"award-info":[{"award-number":["PX2018009"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World j. otorhinolaryngol.-head neck surg."],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the expressions of MAPK10, c\u2010Jun and Itga6 in laryngeal carcinoma and its influence on the sensitivity to docetaxel, cisplatin and 5\u2010fluorouracil (TPF) chemotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Fifty\u2010seven patients with supraglottic squamous cell carcinoma, who were treated by two cycles of TPF induction chemotherapy in our hospital, were enrolled in this study and divided into groups by chemotherapy resistance or chemotherapy sensitivity. The expressions of mRNA and protein of MAPK10, c\u2010Jun and Itga6 in tumor tissues were evaluated by immunohistochemistry. The consistency of mRNA and protein expressions was tested, and the relation with the clinicopathological features was analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The positive rates of MAPK10 andc\u2010Jun in the tumor tissues of the sensitive group were significantly higher than those of there assistant group, which was 90.48% and 100.00%, respectively. The expression rate of Itga6 was significantly higher in the resistant group, which was 83.33% (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). The mRNA levels of MAPK10 and c\u2010Jun were significantly lower in the resistant group than in the sensitive group, whilethemRNA levelof Itga6was significantly higher in the resistant group (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). The protein expressions of MAPK10, c\u2010Jun and Itga6 were consistent with their mRNA expressions (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). The expressions of MAPK10, c\u2010Jun and Itga6 were not correlatedwithage, gender and tumor diameter (<jats:italic>P<\/jats:italic>\u00a0&gt;\u00a00.05). However, the expressions of MAPK10 and c\u2010Jun were negatively correlated withclinical stage and pathological grading (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). Negative correlations between MAPK 10 and Itga6, and between c\u2010Jun and Itga6in tumor tissues were found by Spearman'srank correlation coefficient (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). The correlation was also negative in the resistant tumor tissues (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The MAPK10 and c\u2010Jun expressions were down\u2010regulated, while the Itga6 expression was up\u2010regulated in the chemo\u2010resistant laryngeal carcinoma, and the expression levels of different factors were correlated witheach other. These factorsmight be important biomarkers for predicting outcomes of TPF chemotherapy in laryngeal carcinoma in the future.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.wjorl.2019.05.001","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T19:14:40Z","timestamp":1579893280000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Screening of molecular markers of induced chemotherapy in supraglottic laryngeal squamouscell carcinoma"],"prefix":"10.1002","volume":"6","author":[{"given":"Guang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery Beijing Tongren Hospital Capital Medical Universit Beijing 100730 China"},{"name":"Department of Otorhinolaryngology Head and Neck Surgery Former 263 ClinicalCenter of People's Liberation ArmyGeneral Hospital Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology Beijing 100730 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jugao","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery Beijing Tongren Hospital Capital Medical Universit Beijing 100730 China"},{"name":"Key Laboratory of OtOlaryngology Head and Neck Surgery(Captical Medical University) Ministry of Education Beijing 100730 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery Beijing Tongren Hospital Capital Medical Universit Beijing 100730 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery Beijing Tongren Hospital Capital Medical Universit Beijing 100730 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery Beijing Tongren Hospital Capital Medical Universit Beijing 100730 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery Beijing Tongren Hospital Capital Medical Universit Beijing 100730 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery Beijing Tongren Hospital Capital Medical Universit Beijing 100730 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery Beijing Tongren Hospital Capital Medical Universit Beijing 100730 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery Former 263 ClinicalCenter of People's Liberation ArmyGeneral Hospital Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology Beijing 100730 China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,3]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-016-3922-8"},{"key":"e_1_2_3_3_1","first-page":"13","article-title":"Laryngeal cancer in farmers from Lublin region of Poland","volume":"15","author":"Morshed K.","year":"2008","journal-title":"Ann Agric Environ Med"},{"key":"e_1_2_3_4_1","first-page":"229","article-title":"A systemic evaluation on the efficacy of preferred chemoradiotherapy or surgical treatment for laryngeal carcinoma","volume":"14","author":"Gong H.Y.","year":"2014","journal-title":"J Evidence\u2010Based Med"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv368"},{"key":"e_1_2_3_6_1","first-page":"504","article-title":"A preliminary analysis on potentially targeted genes of induced chemotherapy in supraglottic laryngeal squamous cell carcinoma","volume":"51","author":"Shi Q.","year":"2016","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"e_1_2_3_7_1","first-page":"839","article-title":"Response evaluation criteria in solid tumors and evolution","volume":"18","author":"Zhang H.L.","year":"2010","journal-title":"J Mod Oncol"},{"key":"e_1_2_3_8_1","first-page":"1069","article-title":"Expression and clinical significance of EGFR, HER2 and CXCR4 in non\u2010small cell lung cancer","volume":"14","author":"Liu L.","year":"2014","journal-title":"Prog Mod Biomed"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2014.09.002"},{"key":"e_1_2_3_10_1","volume-title":"A Meta\u2010Analysis on the Efficacy of Total Laryngectomy and Non\u2010surgical Treatment for Locally Advanced Laryngeal Carcinoma [D]","author":"Fu X.Y.","year":"2016"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyx115"},{"key":"e_1_2_3_12_1","first-page":"340","article-title":"Analysis of clinical efficacy in 92 patients with laryngeal carcinoma","volume":"18","author":"Liao F.","year":"2013","journal-title":"Chin Clin Oncol"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.05.004"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3729"},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2694"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.82"},{"key":"e_1_2_3_17_1","first-page":"468","article-title":"Quantitative analysis of integrin \u03b16 in bladder cancer cell lines","volume":"42","author":"Lu W.","year":"2015","journal-title":"Prog Biochem Biophys"}],"container-title":["World Journal of Otorhinolaryngology - Head and Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095881119301027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095881119301027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.wjorl.2019.05.001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1016\/j.wjorl.2019.05.001","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.wjorl.2019.05.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T13:59:03Z","timestamp":1693144743000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1016\/j.wjorl.2019.05.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1016\/j.wjorl.2019.05.001"],"URL":"https:\/\/doi.org\/10.1016\/j.wjorl.2019.05.001","archive":["Portico"],"relation":{},"ISSN":["2095-8811","2589-1081"],"issn-type":[{"value":"2095-8811","type":"print"},{"value":"2589-1081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening of molecular markers of induced chemotherapy in supraglottic laryngeal squamouscell carcinoma","name":"articletitle","label":"Article Title"},{"value":"World Journal of Otorhinolaryngology - Head and Neck Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wjorl.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}